A Maryland man who took Ozempic and then became legally blind is suing the drug's manufacturer, arguing it had an obligation to warn patients that loss of sight could be a possible side effect.

Ozempic may be living up to its reputation ... diabetes who were assigned GLP-1 agonists like semaglutide or an SGLT2 inhibitor to lower blood sugar levels or a placebo. At the start of the ...

The FDA and drugmaker Novo Nordisk on Monday warned that counterfeit vials of Ozempic® (semaglutide) are being sold to consumers and may cause a safety risk. Novo Nordisk cautions pharmacies and ...

MONTGOMERY, Ala. (WSFA) - The FDA is warning people about fake Ozempic after counterfeit vials of the weight loss drug were sold to consumers. In December, the agency said it seized thousands of ...

Plans to file for global approval by end of year Lilly shares rise 16%, Novo Nordisk shares slip Drug could be launched without supply constraints, Lilly says April 17 (Reuters) - Eli Lilly's (LLY ...

Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and Wegovy. The medications have skyrocketed in price and popularity ...

April 14 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain ...

(CNN) - The Food and Drug Administration is warning of fake Ozempic that could pose a safety risk. The FDA and Ozempic manufacturer Novo Nordisk have found counterfeit vials of the weight-loss ...

NORTH CAROLINA -- A warning to consumers about fake Ozempic (semaglutide). The FDA issued this alert saying counterfeits have been found in the US drug supply chain. The FDA and the manufacturer ...

A major international clinical trial has found that Ozempic (semaglutide), a medication already widely used to manage type 2 diabetes and obesity, significantly improves outcomes in patients with ...